- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
Patent holdings for IPC class C12N 15/85
Total number of patents in this class: 10938
10-year publication summary
444
|
513
|
628
|
841
|
833
|
714
|
838
|
890
|
1006
|
672
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Regeneron Pharmaceuticals, Inc. | 4303 |
373 |
The Regents of the University of California | 20015 |
209 |
Massachusetts Institute of Technology | 10080 |
159 |
The Trustees of the University of Pennsylvania | 4328 |
142 |
President and Fellows of Harvard College | 5993 |
137 |
The Broad Institute, Inc. | 1831 |
102 |
The Board of Trustees of the Leland Stanford Junior University | 6441 |
98 |
Sangamo Therapeutics, Inc. | 418 |
75 |
Kymab Limited | 250 |
63 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd | 185 |
60 |
The General Hospital Corporation | 4751 |
58 |
The Johns Hopkins University | 5689 |
57 |
Duke University | 3078 |
56 |
University of Massachusetts | 2231 |
56 |
Modernatx, Inc. | 1262 |
52 |
Novartis AG | 10727 |
51 |
Board of Regents, The University of Texas System | 5828 |
51 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2861 |
48 |
Yale University | 2399 |
46 |
Memorial Sloan-Kettering Cancer Center | 1937 |
41 |
Other owners | 9004 |